We are live on ! Find out more
BCAB icon

BioAtla
BCAB

87 hedge funds and large institutions have $96.1M invested in BioAtla in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 28 increasing their positions, 13 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

115% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 13

90% more call options, than puts

Call options by funds: $55K | Put options by funds: $29K

42% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 19

10% more funds holding

Funds holding: 79 → 87 (+8)

10% more capital invested

Capital invested by funds: $87.6M → $96.1M (+$8.51M)

0.03% less ownership

Funds ownership: 1.37% → 1.34% (-0.03%)

Holders
87
Holders Change
+8
Holders Change %
+10.13%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
28
Reduced
13
Closed
19
Calls
$55K
Puts
$29K
Net Calls
+$26K
Net Calls Change
+$7K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.62M
2
State Street
State Street
Massachusetts
+$1.99M
3
Norges Bank
Norges Bank
Norway
+$1.68M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.57M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.03M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$9.3M
2
CS
Candriam SCA
Luxembourg
-$3.86M
3
APM
Avidity Partners Management
Texas
-$1.61M
4
Citadel Advisors
Citadel Advisors
Florida
-$1.31M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$979K
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
76
Amalgamated Bank
New York
$13K +$14.8K +86 New
Legal & General Group
77
Legal & General Group
United Kingdom
$12.7K +$14.6K +85 New
AIP
78
Ameritas Investment Partners
Nebraska
$11K +$12.6K +73 New
MLICM
79
Metropolitan Life Insurance Company (MetLife)
New York
$7.76K +$8.94K +52 New
Zurich Cantonal Bank
80
Zurich Cantonal Bank
Switzerland
$7.21K -$2.41K -14 -23%
Fidelity Investments
81
Fidelity Investments
Massachusetts
$5.61K -$7.22K -42 -53%
CUAMC
82
China Universal Asset Management Company
China
$1.88K – – –
Group One Trading
83
Group One Trading
Illinois
$1.2K -$1.2K -7 -47%
Daiwa Securities Group
84
Daiwa Securities Group
Japan
$1K – – –
IA
85
IFP Advisors
Florida
$546 – – –
IPW
86
Impact Partnership Wealth
Georgia
$387 +$516 +3 New
NFSG
87
Newbridge Financial Services Group
Florida
$102 – – –
CS
88
Candriam SCA
Luxembourg
– -$3.86M -31,308 Closed
APM
89
Avidity Partners Management
Texas
– -$1.61M -12,050 Closed
Wellington Management Group
90
Wellington Management Group
Massachusetts
– -$979K -7,305 Closed
LCM
91
Laurion Capital Management
New York
– -$784K -5,852 Closed
Marshall Wace
92
Marshall Wace
United Kingdom
– -$766K -5,713 Closed
SFI
93
Susquehanna Fundamental Investments
Pennsylvania
– -$289K -2,156 Closed
Acadian Asset Management
94
Acadian Asset Management
Massachusetts
– -$247K -1,854 Closed
CCM
95
CAAS Capital Management
New York
– -$215K -1,602 Closed
AI
96
Atom Investors
Texas
– -$149K -1,110 Closed
JF
97
Jump Financial
Illinois
– -$125K -936 Closed
AA
98
ALPS Advisors
Colorado
– -$83.4K -622 Closed
OQS
99
Occudo Quantitative Strategies
Florida
– -$58.2K -434 Closed
Squarepoint
100
Squarepoint
New York
– -$51.4K -384 Closed
1 2 3
4
5

BCAB Hedge Fund Activity: Q2 2023 in Review

87 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q2 2023, worth a combined $96.1M — up 9.7% from $87.6M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new BCAB positions and 19 closed out — a net gain of 8 holders — while 28 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $7.62M. The largest seller was OrbiMed, cutting an estimated $9.3M.

  • 87 institutional investors held BioAtla (BCAB) as of Q2 2023, up from 79 in Q1 2023.
  • Funds reported $96.1M of BioAtla stock for Q2 2023, up 9.7% quarter-over-quarter.
  • 27 funds opened new BioAtla positions in Q2 2023 and 19 closed out, a net change of +8 holders.
  • The largest BioAtla buyer in Q2 2023 was BlackRock, an estimated $7.62M added.
  • The largest BioAtla seller in Q2 2023 was OrbiMed, an estimated $9.3M sold.

Based on aggregated 13F filings for Q2 2023.